MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2019 International Congress

    Investigating the cellular role of LRRK2 in the immune system

    I. Nazish, R. Bandopadhyay (London, United Kingdom)

    Objective: The objective of this project is to investigate the effect of Leucine Rich-Repeat Kinase 2 (LRRK2) dysfunction in the signalling mechanisms in macrophages and…
  • 2019 International Congress

    Ambulatory monitoring of electrodermal activity (EDA) and Heart Rate Variability (HRV) for prediction of motor fluctuations in Parkinson’s Disease (PD)

    D. Nene, P. Surathi, M. Mirian, W. Doo, M. Mckeown (Vancouver, BC, Canada)

    Objective: To determine whether changes in EDA and HRV are associated with motor fluctuations in patients with PD Background: EDA and HRV are affected in…
  • 2019 International Congress

    Special features of parkinsonism with congenital anomalies of cerebral vessels

    AS. Norboboev, FAY. Odinaev, GUL. Rakhmatullaeva (Tashkent, Uzbekistan)

    Objective: To study the features of the flow of parkinsonism with congenital anomalies of cerebral vessels. Background: Analysis of the study of neurological status, data…
  • 2019 International Congress

    Parkinsonian syndrome associated to C9orf72 expansion

    S. Novo Ponte, E. Gamo González, P. Sánchez Alonso (Majadahonda, Spain)

    Objective: To describe a case of parkinsonian syndrome associated to C9Orf72 expansion followed by ALS development Background: C9Orf72 expansions are known to be the most…
  • 2019 International Congress

    Glabellar tap predicts dopamine transporter deficiency in parkinsonism

    S. Nuuttila, J. Joutsa, M. Eklund, E. Jaakkola, E. Mäkinen, T. Noponen, T. Ihalainen, F. Scheperjans, V. Kaasinen (Turku, Finland)

    Objective: The objective of this study was to investigate the association between glabellar tap findings with nigrostriatal dopamine function in patients with unclear parkinsonism. Background:…
  • 2019 International Congress

    Multiple system atrophy with predominant striato-nigral degeneration (MSA-P) and TDP-43 pathology: an unusual pathologic variant of MSA

    L. Nwabuobi, D. Tomishon, N. Shneider, S. Fahn, J. Vonsattel, E. Cortes (New York, NY, USA)

    Objective: To report a patient with MSA with concomitant occurrence of TDP-43-labeled and a-synuclein labeled inclusions in oligodendrocytes. Background: The pathologic hallmark in multiple system atrophy…
  • 2019 International Congress

    PARKINSON DISEASE HAMPERS PARTICIPATION IN THE CIVIC RESPONSIBILITY OF VOTING: a study of barriers to expression of a fundamental human right

    O. Oguntunde, O. Ojo, O. Agabi, M. Rizig, N. Okubadejo (Lagos, Nigeria)

    Objective: To determine the impact of PD on the participation of persons with Parkinson disease in the recently concluded national elections in Lagos,Nigeria, and explore…
  • 2019 International Congress

    Blood brain barrier dysfunction cause idiopathic adult onset ventriculomegaly?

    E. Oh, H. Chang, S. Kim, S. Kim, J. Heo (Daejeon, Republic of Korea)

    Objective: Our hypothesis is BBB disruption causes idiopathic adult onset ventriculomegaly (IAOV) also, astrocyte specific mitochondrial dysfunction is associated with BBB damage. Background: The cause…
  • 2019 International Congress

    Efficacy, Safety, and Tolerability of Supratherapeutic Doses of Apomorphine Sublingual Film for the Treatment of “OFF” Episodes in Patients With Parkinson’s Disease

    C. Olanow, F. Stocchi, K. Wilks, E. Peckham, M. de Pandis, K. Sciarappa, R. Kleiman, D. Blum, B. Navia (New York, NY, USA)

    Objective: To evaluate efficacy, safety, and tolerability of supratherapeutic doses of apomorphine sublingual film (APL-130277; APL) in patients with Parkinson’s disease (PD) and “OFF” episodes.…
  • 2019 International Congress

    Pharmacokinetics of Accordion Pill™ Carbidopa/Levodopa Following Multiple Doses in Patients With Parkinson’s Disease

    C. Olanow, F. Stocchi, M. Leinonen, N. Navon, J. Meckler, R. Gendreau (Sarasota, FL, USA)

    Objective: To perform a pharmacokinetic (PK) assessment of a novel carbidopa/levodopa drug delivery system (Accordion Pill™; AP-CD/LD) and to determine if multiple doses of AP-CD/LD…
  • « Previous Page
  • 1
  • …
  • 1291
  • 1292
  • 1293
  • 1294
  • 1295
  • …
  • 1942
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley